EP2685986

GLUCOSYLCERAMIDE SYNTHASE INHIBITOR

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.3.2012
  • EP published:
    27.11.2019
  • EP application number:
    12760259.7
  • Max expiry date:
    15.3.2032
  • Expiry date:
    15.3.2021
  • Title:
    GLUCOSYLCERAMIDE SYNTHASE INHIBITOR

Timeline

Today
16.3.2012EP application
27.11.2019EP Publication
15.3.2021Expires

Owner

  • Name:
    Genzyme Corporation
  • Address:
    50 Binney Street, 02142, Cambridge, MA, US

Inventor

  • Name:
    BOURQUE, Elyse
  • Address:
    Waltham, MA, US
  • Name:
    CELATKA, Cassandra
  • Address:
    Waltham, MA, US
  • Name:
    HIRTH, Bradford
  • Address:
    Waltham, MA, US
  • Name:
    METZ, Markus
  • Address:
    Waltham, MA, US
  • Name:
    ZHAO, Zhong
  • Address:
    Waltham, MA, US
  • Name:
    SKERLJ, Renato
  • Address:
    Waltham, MA, US
  • Name:
    XIANG, Yibin
  • Address:
    Waltham, MA, US
  • Name:
    JANCISICS, Katherine
  • Address:
    Waltham, MA, US
  • Name:
    MARSHALL, John
  • Address:
    Framingham, MA, US
  • Name:
    CHENG, Seng
  • Address:
    Framingham, MA, US
  • Name:
    SCHEULE, Ronald
  • Address:
    Framingham, MA, US
  • Name:
    CABRERA-SALAZAR, Mario
  • Address:
    Framingham, MA, US
  • Name:
    GOOD, Andrew
  • Address:
    Waltham, MA, US

Priority

  • Number:
    201161454034 P
  • Date:
    18.3.2011
  • Country:
    US
  • Number:
    201261590711 P
  • Date:
    25.1.2012
  • Country:
    US

Classification

  • Categories:
    A61K 31/439, C07D 453/02, A61K 45/06, A61K 38/47, A61P 3/00, A61P 35/00, A61P 43/00

Annual fees

Number

Paid

Expires

Payer

Number: 9

Paid: 18.2.2020

Expires: 15.3.2021

Payer: Árnason Faktor ehf.

Upload documents